Sight Sciences (SGHT) Return on Capital Employed (2021 - 2026)
Sight Sciences (SGHT) posted quarterly Return on Capital Employed of 37.79% for Q1 2026, up 222.0% year-over-year from 11.74% in Q1 2025, and down 6.71% quarter-over-quarter from 35.42% in Q4 2025.
Sight Sciences (SGHT) Return on Capital Employed (2021 - 2026) Analysis & Trends
Sight Sciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 37.79% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 222.0% year-over-year to 37.79%; the TTM figure through Mar 2026 stood at 37.79% (up 222.0% YoY), while the FY2025 annual figure was 31.43%, up 485.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 37.79%, down from 35.42% in the prior quarter.
- The five-year high for Return on Capital Employed was 24.09% in Q1 2022, with the low at 42.75% in Q2 2025.
- The 5-year median for Return on Capital Employed is 37.86% (2022), against an average of 37.65%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed tumbled 2278 bps in 2022, then soared 577 bps in 2023.
- Sight Sciences' Return on Capital Employed stood at 41.7% in 2022, then grew by 14 bps to 35.93% in 2023, then slipped by 10 bps to 39.56% in 2024, then increased by 10 bps to 35.42% in 2025, then declined by 7 bps to 37.79% in 2026.
- Business Quant data shows SGHT's Return on Capital Employed at 37.79% in Q1 2026, 35.42% in Q4 2025, and 42.28% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Sight Sciences | 445.04 Mn | 365.29 Mn | 21.37 Mn | -32.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.12% |
| Mar 31, 2026 | -37.79% |
| Dec 31, 2025 | -35.42% |
| Sep 30, 2025 | -42.28% |
| Jun 30, 2025 | -42.75% |
| Mar 31, 2025 | -40.01% |
| Dec 31, 2024 | -39.56% |
| Sep 30, 2024 | -37.42% |
| Jun 30, 2024 | -37.24% |
| Mar 31, 2024 | -36.43% |
| Dec 31, 2023 | -35.93% |
| Sep 30, 2023 | -37.94% |
| Jun 30, 2023 | -40.50% |
| Mar 31, 2023 | -41.82% |
| Dec 31, 2022 | -41.70% |
| Sep 30, 2022 | -37.86% |
| Jun 30, 2022 | -31.34% |
| Mar 31, 2022 | -24.09% |
| Dec 31, 2021 | -18.92% |
| Sep 30, 2021 | -27.99% |